Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: Involvement of benzodiazepine and opioid receptors

BMC Complementary and Alternative Medicine

Volumn 7, Issue , 2007, Pages

  Nassiri Asl, Marjan ^a   Shariati Rad, Schwann ^a   Zamansoltani, Farzaneh ^a  

^a Qazvin University   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; DIAZEPAM; FLUMAZENIL; NALOXONE; OPIATE RECEPTOR; PASIPAY; PASSIFLORA INCARNATA EXTRACT; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; ANTIDOTE; CONVULSANT AGENT; NARCOTIC ANTAGONIST; PENTETRAZOLE; PLANT EXTRACT; SODIUM CHLORIDE;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DISEASE DURATION; DRUG MECHANISM; GABAERGIC SYSTEM; MALE; MORTALITY; MOUSE; NEUROPROTECTION; NONHUMAN; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; INTRAPERITONEAL DRUG ADMINISTRATION; METHODOLOGY; PASSION FRUIT; PHYTOTHERAPY; PLANT; TREATMENT OUTCOME;

ANIMALS; ANTICONVULSANTS; ANTIDOTES; CONVULSANTS; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EPILEPSY, ABSENCE; FLUMAZENIL; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED BALB C; NALOXONE; NARCOTIC ANTAGONISTS; PASSIFLORA; PENTYLENETETRAZOLE; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; RECEPTORS, GABA-A; RECEPTORS, OPIOID; SODIUM CHLORIDE; TREATMENT OUTCOME;

EID: 34548572963     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-7-26     Document Type: Article

References (41)

1. Poole K Moran N Bell G Solomon J Kendall S McCarthy M McCormick D Nashef L Johnson A Sander J Shorvon S Patients' perspectives on services for epilepsy: A survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy Seizure 2000, 9(8):551-558 10.1053/seiz.2000.0450 11162752
2. Ropper AH Brown RH Epilepsy and other seizures disorder Adams and Victor's Principles of Neurology New York: McGraw-Hill Ropper AH, Brown RH 8 2005:271-297
3. Samren EB van Duijn CM Koch S Hiilesmaa VK Klepel H Bardy AH Mannagetta GB Deichl AW Gaily E Granstrom ML Meinardi H Grobbee DE Hofman A Janz D Lindhout D Maternal use of antiepileptic drugs and the risk of major congenital malformations: A joint European prospective study of human teratogenesis associated with maternal epilepsy Epilepsia 1997, 38(9):981-990 10.1111/j.1528-1157.1997.tb01480.x 9579936
4. Raza M Shaheen F Choudhary MI Rahman AU Sombati S Suria A Rafiq A DeLorenzo RJ Anticonvulsant effect of FS-1 subfraction isolated from roots of Delphinim Denudatum on hippocampal pyramidal neurons Phytotherapy Res 2003, 17(1):38-43 10.1002/ptr.1072
5. Nsour WM Lau CB Wong IC Review on phytotherapy in epilepsy Seizure 2000, 9(2):96-107 10.1053/seiz.1999.0378 10845732
6. Sucher NJ Insights from molecular investigations of traditional Chinese herbal stroke medicines: Implications for neuroprotective epilepsy therapy Epilepsy Behav 2006, 8(2):350-362 10.1016/j.yebeh.2005.11.015 16455305
7. Koehn FE Carter GT The evolving role of natural products in drug discovery Nat Rev Drug Discov 2005, 4(3):206-220 10.1038/nrd1657 15729362
8. Newman DJ Cragg GM Snader KM Natural products as sources of new drugs over the period 1981 - 2002 J Nat Prod 2003, 66(7):1022-1037 10.1021/ np030096l 12880330
9. Gorji A Khaleghi Ghadiri M History of epilepsy in Medieval Iranian medicine Neurosci Biobehav Rev 2001, 25(5):455-461 10.1016/ S0149-7634(01)00025-2 11566482
10. Zargari A Medicinal plants Tehran: Tehran University 1989
11. Kinghorn GR Passion, stigma, and STI Sex Transm Inf 2001, 77(5):370-375 10.1136/sti.77.5.370
12. Dhawan K Dhawan S Sharma A Passiflora: A review update J Ethnopharmacol 2004, 94(1)1-23 10.1016/j.jep.2004.02.023 15261959
13. Akhondzadeh S Naghavi HR Vazirian M Shayeganpour A Rashidi H Khani M Passionflower in the treatment of generalized anxiety disorder: A pilot double-blind randomized controlled trial with oxazepam J Clin Pharm Ther 2001, 26 (5):363-367 10.1046/j.1365-2710.2001.00367.x 11679026
14. Reginatto FH De-Paris F Petry RD Quevedo J Ortega GG Gosmann G Schenkel EP Evaluation of anxiolytic activity of spray dried powders of two South Brazilian Passiflora species Phytother Res 2006, 20 (5):348-351 10.1002/ ptr.1853 16619361
15. Wheatley D Medicinal plants for insomnia: A review of their pharmacology, efficacy and tolerability J Psychopharmacol 2005, 19(4):414-421 10.1177/0269881105053309 15982998
16. Akhundzadeh S Mohammadi MR Momeni F Passiflora incarnata in treatment of attention-deficit hyperactivity disorder in children and adolescents Therapy 2005, 2(4): 609-614 10.1586/14750708.2.4.609
17. Ichimura T Yamanaka A Ichiba T Toyokawa T Kamada Y Tamamura T Maruyama S Antihypertensive effect of an extract of Passiflora edulis rind in spontaneously hypertensive rats Biosci Biotechnol Biochem 2006, 70(3):718-721 10.1271/bbb.70.718 16556991
18. Rowe CA Nantz MP Deniera C Green K Talcott ST Percival SS Inhibition of neoplastic transformation of benzo[alpha]pyrene-treated BALB/c 3T3 murine cells by a phytochemical extract of passionfruit juice J Med Food 2004, 7(4):402-407 10.1089/jmf.2004.7.402 15671681
19. Dhawan K Kumar S Sharma A Evaluation of central nervous system effects of Passiflora incarnata in experimental animals Pharmaceutical Biology 2003, 41(2):87-91
20. Akhondzadeh S Kashani L Mobaseri M Hosseini SH Nikzad S Khani M Passionflower in the treatment of opiates withdrawal: A double-blind randomized controlled trial J Clin Pharm Ther 2001, 26(5):369-373 10.1046/j.1365-2710.2001.00366.x 11679027
21. Fernandez SP Wasowski C Loscalzo LM Granger RE Johnston GA Paladini AC Marder M Central nervous system depressant action of flavonoid glycosides Eur J Pharmacol 2006, 539(3):168-176 10.1016/ j.ejphar.2006.04.004 16698011
22. Soulimani R Younos C Jarmouni S Bousta D Misslin R Mortier F Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse J Ethnopharmacol 1997, 57(1):11-20 10.1016/S0378-8741(97)00042-1 9234160
23. Vogel HG Vogel WH Drug Discovery and Evaluation, Pharmacological Assay Berlin: Springer 1997
24. File SE Pellow S Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788 Psychopharmacology 1986, 88(1):1-11 10.1007/ BF00310505 3003778
25. Hosseinzadeh H Parvardeh S Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice Phytomedicine 2004, 11(1):56-64 10.1078/0944-7113-00376 14971722
26. Hosseinzadeh H Parvardeh S Nassiri-Asl M Mansouri MT Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppress epileptic seizures in rats Med Sci Monit 2005, 11(4):BR106-110 15795687
27. Lauretti GR Ahmad I Pleuvry BJ The activity of opioid analgesics in seizure models utilizing N-methyl-D-aspartic acid, kainic acid, bicuculline and pentylenetetrazole Neuropharmacology 1994, 33(2):155-160 10.1016/0028-3908(94)90002-7 7913538
28. Kaminski RM Witkin JM Shippenberg TS Pharmacological and genetic manipulation of kappa opioid receptors: Effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling Neuropharmacology 2007, 52(3):895-903 10.1016/j.neuropharm.2006.10.007 17126860
29. Shinomiya K Inoue T Utsu Y Tokunaga S Masuoka T Ohmori A Kamei C Hypnotic activities of chamomile and Passiflora extracts in sleep-disturbed rats Biol Pharm Bull 2005, 28(5):808-810 10.1248/ bpb.28.808 15863883
30. Dhawan K Kumar S Sharma A Anti-anxiety studies on extracts of Passiflora incarnata Linneaus J Ethnopharmacol 2001 78(2-3):165-170 10.1016/ S0378-8741(01)00339-7 11694362
31. Zanoli P Avallone R Baraldi M Behavioral characterisation of the flavonoids apigenin and chrysin Fitoterapia 2000, 71(Suppl 1):S117-S123 10.1016/S0367-326X(00)00186-6 10930722
32. Muller SD Vasconcelos SB Coelho M Biavatti MW LC and UV determination of flavonoids from Passiflora alata medicinal extracts and leaves J Pharm Biomed Anal 2005, 37(2):399-403 10.1016/j.jpba.2004.10.047 15708685
33. Dhawan K Kumar S Sharma A Comparative anxiolytic activity profile of various preparations of Passiflora incarnata linneaus: A comment on medicinal plants standardization J Altern Complement Med 2002, 8(3):283-291 10.1089/10755530260127970 12165186
34. Riazi K Honar H Homayoun H Rashidi N Deghani M Sadeghipour H Gaskari SA Dehpour AR Sex and esterus cycle differences in the modulatory effects of morphine on seizure susceptibility in mice Epilepsia 2004, 45(9):1035-1042 10.1111/j.0013-9580.2004.69903.x 15329066
35. Speroni E Minghetti A Neuropharmacological activity of extracts from Passiflora incarnata Planta Med 1988, 54(6):488-491 10.1055/ s-2006-962525 3212072
36. Yajima Y Narita M Takahashi-Nakano Y Misawa M Nagase H Mizoguchi H Tseng LF Suzuki T Effects of differential modulation of μ-, δ- and κ-opioid systems on bicuculline-induced convulsions in the mouse Brain Res 2000, 862(1-2):120-126 10.1016/S0006-8993(00)02096-5 10799676
37. Manocha A Mediratta PK Sharma KK Studies on the anticonvulsant effect of U50488H on maximal electroshock seizure in mice Pharmacol Biochem Behav 2003, 76(1):111-117 10.1016/S0091-3057(03)00218-1 13679223
38. VonVoigtlander PF Hall ED Ochoa MC Lewis RA Triezenberg HJ U-54494A: A unique anticonvulsant related to kappa opioid agonists J Pharmacol Exp Ther 1987. 243(2):542-547 2824750
39. Becker A Braun H Schroder H Grecksch G Hollt V Effects of enadoline on the development of pentylenetetrazol kindling, learning performance, and hippocampal morphology Brain Res 1999, 823(1-2):191-197 10.1016/ S0006-8993(99)01189-0 10095026
40. Rawls SM McGinty JF Kappa receptor activation attenuates L-trans- pyrrolidine-2, 4-dicarboxylic acid-evoked glutamate levels in the striatum J Neurochem 1998, 70(2):626-634 9453556
41. Wagner JJ Caudle RM Chavkin C Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus J Neurosci 1992, 12:132-141 1345943